US EditionPublished • loading... • Updated
Many Americans Will Soon Have Access to At-Home Cervical Cancer Screening Tests at No Cost
HRSA's updated guidance endorses FDA-approved at-home HPV self-testing covered by private insurers from 2027 to increase screening access and early cervical cancer detection.
- On Monday, the Department of Health and Human Services updated HRSA guidance to allow at-home HPV testing by prescription, with private insurers required to cover it starting January 1, 2027.
- Amid falling screening rates since 2021, HRSA aims to reach people missed by screening and build on the last 50 years' progress where incidence and deaths fell by more than 50%.
- Regulatory clearances now permit self-collection both in clinics and, for one device, at home; HRSA recommends only FDA-approved self-collection tests, which can be clinician- or patient-collected.
- Engels said the updates will improve screening rates and save lives, requiring private insurers to cover follow-up testing without cost-sharing, while CDC data show over 90% five-year survival with early detection.
- The American Cancer Society's updated guidance notes recommend primary HPV testing from age 25 and at-home testing every three years, while rising rates in women in their 30s and 40s and about 13,000 annual U.S. cases highlight ongoing risks.
Insights by Ground AI
Podcasts & Opinions
19 Articles
19 Articles
Many Americans Will Soon Have Access to At-Home Cervical Cancer Screening Tests at No Cost
U.S. guidance announced on Monday recommends self-collection of samples to test for HPV, the virus that often causes cervical cancer. Private insurers must cover the costs of the swab kits by 2027
·United States
Read Full Article
Federal guidelines for cervical cancer screening now include self-collection option
HHS’s Health Resources and Services Administration released updated guidance for cervical cancer screening, which includes a new option for average-risk women to self-collect vaginal samples for HPV testing.The guidance, published in JAMA, “is designed to help close the screening gap by expanding access and reducing cost barriers,” HRSA told Healio.
Coverage Details
Total News Sources19
Leaning Left3Leaning Right0Center6Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
